Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
NCT ID: NCT01156415
Last Updated: 2020-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
837 participants
INTERVENTIONAL
2010-06-30
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cohort I is restricted to include patients who have completed a previous Novartis agomelatine (178C) Double-blind study.
Cohort II will include de-novo patients (those who did not participate in a previous agomelatine 178C study) and will only be open for a limited time span ranging from approximately June to Sept 2010, at which point this cohort II will be closed to enrollment.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Agomelatine (AGO178) 0.5 mg
AGO178
Agomelatine (AGO178) 1 mg
AGO178
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AGO178
AGO178
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female adults, 18 through 71 years of age, inclusive (i.e., same age range as for Double-blind Study, but with upper age limit increased by 1-year to accommodate patients whose age increased during the Double-blind Study).
* Female patients should continue to use effective contraception as defined in double-blind study protocol.
* Male and female adults, 18 through 70 years of age, inclusive.
* Diagnosis of MDD, single or recurrent episode, according to DSM-IV criteria.
* Current episode ≥4 weeks.
* CGI-Severity score ≥4 at Screening and Baseline.
Exclusion Criteria
* Any significant medical condition that emerged during Double-blind Phase of a previous study, which may interfere with study participation and/or study assessments as assessed by the investigator.
* History of bipolar disorder (I or II), schizophrenia, schizoaffective disorder, eating disorder (current or during previous one year), obsessive-compulsive disorder.
* Any other current Axis I disorder other than MDD which is the focus of treatment.
* Substance or alcohol abuse in the last 30 days, dependence in the last 6 months.
* Prior exposure to agomelatine.
* Female patients of childbearing potential who are not using effective contraception.
18 Years
71 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Advanced Research Associates
Glendale, Arizona, United States
Southwest Health Ltd dba The Mollen Clinic
Scottsdale, Arizona, United States
Clinical Study Centers, LLC
Little Rock, Arkansas, United States
Southwestern Research Institute
Beverly Hills, California, United States
Comprehensive Neuroscience
Cerritos, California, United States
ATP Clinical Research, Inc
Costa Mesa, California, United States
Collaborative Neuroscience Network
Garden Grove, California, United States
Pharmacology Research Institute
Newport Beach, California, United States
Pacific Clinical Research Medical Group
Orange, California, United States
CNRI-San Diego, LLC
San Diego, California, United States
University of California, San Diego Medical Center
San Diego, California, United States
Neuropsychiatric Research Center of Orange County
Santa Ana, California, United States
Viking Clinical Research Center
Temecula, California, United States
Collaborative Neuroscience
Torrance, California, United States
University of Colorado
Aurora, Colorado, United States
Western Affiliated Research Institute
Denver, Colorado, United States
Middlesex Hospital
Middletown, Connecticut, United States
Clinical Studies
Altamonte Springs, Florida, United States
Florida Clinical Research Center, LLC
Bradenton, Florida, United States
Arocha Research Center
Coral Gables, Florida, United States
CNS Clinical Research
Coral Springs, Florida, United States
Sjs Clinical Research
Destin, Florida, United States
MD Clinical
Hallandale, Florida, United States
CNS Healthcare
Jacksonville, Florida, United States
Florida Clinical Research Center
Maitland, Florida, United States
CNS Healthcare
Orlando, Florida, United States
Quantum Lab. at N. Broward Memory Disorder Center
Pompano Beach, Florida, United States
Miami Research Associates
South Miami, Florida, United States
Comprehensive NeuroScience, Inc.
St. Petersburg, Florida, United States
Janus Center for Psychiatric Research
West Palm Beach, Florida, United States
Emory University
Atlanta, Georgia, United States
Atlanta Center for Medical Research
Atlanta, Georgia, United States
Northwest Behavioral Research Center
Marietta, Georgia, United States
Hawaii Clinical Research Center
Honolulu, Hawaii, United States
Alexian Brothers Center for Psychiatric Research
Hoffman Estates, Illinois, United States
Joliet Center for Clinical Research
Joliet, Illinois, United States
Capstone Clinical Research
Libertyville, Illinois, United States
Rush University Medical Center
Skokie, Illinois, United States
Deaconess Clinic Gateway
Newburgh, Indiana, United States
Pharmasite Research
Pikesville, Maryland, United States
Boston Clinical Trials
Boston, Massachusetts, United States
Mount Auburn Medical Associates
Watertown, Massachusetts, United States
Coastal Research Associates
Weymouth, Massachusetts, United States
Michigan State University
East Lansing, Michigan, United States
Pine Rest Christian Mental Health Services
Grand Rapids, Michigan, United States
Rochester Center for Behavioral Medicine
Rochester Hills, Michigan, United States
Comprehensive Psychiatric Associates
Gladstone, Missouri, United States
Robert Wood Johnson Medical School
Piscataway, New Jersey, United States
Bio Behavioral Health
Toms River, New Jersey, United States
CRI Worldwide
Willingboro, New Jersey, United States
Albuquerque Neuroscience
Albuquerque, New Mexico, United States
Neurological Associates Of Albany
Albany, New York, United States
Social Psychiatry Research, Inc./ SPRI
Brooklyn, New York, United States
Neurobehavioral Research, Inc.
Cedarhurst, New York, United States
Eastside Comprehensive Medical Service
New York, New York, United States
Medical & Behavior Health Research
New York, New York, United States
The Medical Research Network, LLC
New York, New York, United States
Richmond Behavioral Associates
Staten Island, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Pharmquest
Greensboro, North Carolina, United States
Zarzar Psychiatric Associates
Raleigh, North Carolina, United States
Piedmont Medical Research Associates, Inc.
Winston-Salem, North Carolina, United States
Odyssey Research Services
Fargo, North Dakota, United States
Neuro Behavioral Clinical Research
Canton, Ohio, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
North Star Medical Research
Cleveland, Ohio, United States
The Ohio State Universtiy - Harding Hospital
Columbus, Ohio, United States
Neurology & Neuroscience Center of Ohio
Toledo, Ohio, United States
IPS Research
Oklahoma City, Oklahoma, United States
SP Research
Oklahoma City, Oklahoma, United States
Cutting Edge Research
Oklahoma City, Oklahoma, United States
Sunstone Medical Research, LLC
Medford, Oregon, United States
Oregon Center for Clinical Investigations
Portland, Oregon, United States
Summit Research
Portland, Oregon, United States
Lehigh Center for Clinical Research
Allentown, Pennsylvania, United States
Suburban Research Associates
Media, Pennsylvania, United States
CRI Worldwide, LLC
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
Research Strategies of Memphis
Memphis, Tennessee, United States
Clinical Research Associates
Nashville, Tennessee, United States
Millwood Hospital
Arlington, Texas, United States
FutureSearch Trials of Dallas
Dallas, Texas, United States
InSite Clinical Research
DeSoto, Texas, United States
Bayou City Research Limited
Houston, Texas, United States
Claghorn Lesem Research Clinic, Inc.
Houston, Texas, United States
Texas Center for Drug Development
Houston, Texas, United States
Grayline Clinical Drug Trials
Wichita Falls, Texas, United States
Radiant Research
Salt Lake City, Utah, United States
University of Utah Mood Disorders Clinic
Salt Lake City, Utah, United States
Alliance Research Group, LLC
Richmond, Virginia, United States
Northwest Clinical Research Center
Bellevue, Washington, United States
Frontier Institute
Spokane, Washington, United States
Independent Psychiatric Consultants
Waukesha, Wisconsin, United States
Centro de Investigacion Clinica Psiquiatrica
Ponce, , Puerto Rico
Dharma Institute and Research Center
San Juan, , Puerto Rico
INSPIRA Clinical Research
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Results for CAGO178C2399 from the Novartis Clinical Trials website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAGO178C2399
Identifier Type: -
Identifier Source: org_study_id